Progesterone is known to be a major factor driving ER/PR-negative breast cancer by stimulating the secretion of RANKL and other factors in ER+/PR+ luminal mature cells which activate the expansion of ER−/PR− luminal progenitor cells eventually leading to highly aggressive cancer. The gene discussed is TNFSF11; the disease is cancer.